Author

A. TURHAN

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Bennaceur Griscelli· 2 shared C. Desterke· 2 shared F. Griscelli· 2 shared A. Asgorava· 1 shared A. Bennaceur· 1 shared D. Chaker· 1 shared G. Telliam· 1 shared J. C. Chomel· 1 shared

Activity by Year

2019-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Bennaceur Griscelli

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Evidence of Increased Hemangioblastic and Early Hematopoietic Potential in Chronic Myeloid Leukemia (CML)-derived Induced Pluripotent Stem Cells (iPSC)

G. Telliam, O. Feraud, S. Baykal, F. Griscelli, J. Imeri, T. Latsis, A. Bennaceur Griscelli, A. TURHAN

This study shows that CML-derived iPSC have expanded hemangioblast and hematopoietic progenitor potential compared to H1-ESC, with AHR signaling as a potential therapeutic target.

bioRxiv · Jun 17, 2020Cancer Biology

Pharmacologically modified pluripotent stem cell-based cancer vaccines with anti-metastatic potential

M. Heront-Kishi, A. Asgorava, C. Desterke, D. Chaker, M. G. de Goer, A. TURHAN, A. Bennaceur, F. Griscelli

This study shows that combining pluripotent stem cells with a histone deacetylase inhibitor can create an effective cancer vaccine that targets cancer stem cells and reduces metastasis in breast cancer.

bioRxiv · May 27, 2020 · PreprintCancer Biology

Evidence of massive leukemic progenitor expansion in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML)

A. Turhan, P. Hugues, N. Sorel, C. Desterke, J. H. Bourhis, A. Bennaceur Griscelli, J. C. Chomel

The paper shows that leukemic progenitor expansion occurs in peripheral blood before cytological changes in CML patients after TKI discontinuation.

bioRxiv · Oct 22, 2019Cancer Biology